{
    "organizations": [],
    "uuid": "e09fe1a7369162d5e82adeaa05b0313b43d6dfde",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/markets-swiss-stocks/swiss-stocks-factors-to-watch-on-march-27-idUSL8N1R85H5",
    "ord_in_thread": 0,
    "title": "Swiss stocks - Factors to watch on March 27",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "ZURICH, March 27 (Reuters) - The Swiss blue-chip SMI was seen opening 1.2 percent higher at 8,613 points on Tuesday, according to premarket indications by bank Julius Baer . Here are some of the main factors that may affect Swiss stocks.\nNOVARTIS GlaxoSmithKline will buy Novartis’s NOVN.S 36.5 percent stake in their consumer healthcare joint venture for $13.0 billion in cash, the partners said on Tuesday.\nFor more news, click on\nNESTLE The company is launching a lower-sugar Milkybar made with a new version of the sweetener which could help ease the $185 billion confectionery industry’s growing public health headache.\nFor more news, click on\nCOMPANY STATEMENTS * ABB said it has priced the $1.5 billion bond offering it has launched, with the funds being earmarked for general corporate purposes and a portion of its acquisition of GE’s Industrial Solutions business.\n* Sensirion said the over-allotment option has been fully exercised in its upcoming initial public offering.\n* Baloise reported full year profit attributable to shareholders up 2.5 percent at 548.0 million Swiss francs.\n* Novartis Chief Executive Vas Narasimhan aims to more than double the pharmaceutical company’s sales in China over the next five years and gain faster reimbursement for cutting-edge cancer drugs as the country speeds up approvals, Bloomberg reported.\n* Ypsomed said it has established its first subsidiary in Canada.\n* Schmolz + Bickenbach said it will propose Isabel Corinna Knauf as a new independent member of the board of directors at its AGM. Two current members Vladimir Polienko and Dr Heinz Schumacher will not stand for re-election.\n* Cassiopea, a clinical stage speciality pharmaceutical company focused on medical dermatology products, has announced the lists of candidates proposed for the board of directors at its AGM next month.\n* SHL Telemedicine reported full year net profit of $2.4 million. [SHLTN.S>]\n* Warteck Invest reported full year profit of 16.4 million Swiss francs.\n* Vifor Pharma said it has concluded a agreement with Zeria to market Veltassa in Japan.\nReporting by Zurich newsroom\n ",
    "published": "2018-03-27T13:02:00.000+03:00",
    "crawled": "2018-03-28T18:53:52.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "zurich",
        "march",
        "reuters",
        "swiss",
        "smi",
        "seen",
        "opening",
        "percent",
        "higher",
        "point",
        "tuesday",
        "according",
        "premarket",
        "indication",
        "bank",
        "julius",
        "baer",
        "main",
        "factor",
        "may",
        "affect",
        "swiss",
        "stock",
        "novartis",
        "glaxosmithkline",
        "buy",
        "novartis",
        "percent",
        "stake",
        "consumer",
        "healthcare",
        "joint",
        "venture",
        "billion",
        "cash",
        "partner",
        "said",
        "tuesday",
        "news",
        "click",
        "nestle",
        "company",
        "launching",
        "milkybar",
        "made",
        "new",
        "version",
        "sweetener",
        "could",
        "help",
        "ease",
        "billion",
        "confectionery",
        "industry",
        "growing",
        "public",
        "health",
        "headache",
        "news",
        "click",
        "company",
        "statement",
        "abb",
        "said",
        "priced",
        "billion",
        "bond",
        "offering",
        "launched",
        "fund",
        "earmarked",
        "general",
        "corporate",
        "purpose",
        "portion",
        "acquisition",
        "ge",
        "industrial",
        "solution",
        "business",
        "sensirion",
        "said",
        "option",
        "fully",
        "exercised",
        "upcoming",
        "initial",
        "public",
        "offering",
        "baloise",
        "reported",
        "full",
        "year",
        "profit",
        "attributable",
        "shareholder",
        "percent",
        "million",
        "swiss",
        "franc",
        "novartis",
        "chief",
        "executive",
        "va",
        "narasimhan",
        "aim",
        "double",
        "pharmaceutical",
        "company",
        "sale",
        "china",
        "next",
        "five",
        "year",
        "gain",
        "faster",
        "reimbursement",
        "cancer",
        "drug",
        "country",
        "speed",
        "approval",
        "bloomberg",
        "reported",
        "ypsomed",
        "said",
        "established",
        "first",
        "subsidiary",
        "canada",
        "schmolz",
        "bickenbach",
        "said",
        "propose",
        "isabel",
        "corinna",
        "knauf",
        "new",
        "independent",
        "member",
        "board",
        "director",
        "agm",
        "two",
        "current",
        "member",
        "vladimir",
        "polienko",
        "dr",
        "heinz",
        "schumacher",
        "stand",
        "cassiopea",
        "clinical",
        "stage",
        "speciality",
        "pharmaceutical",
        "company",
        "focused",
        "medical",
        "dermatology",
        "product",
        "announced",
        "list",
        "candidate",
        "proposed",
        "board",
        "director",
        "agm",
        "next",
        "month",
        "shl",
        "telemedicine",
        "reported",
        "full",
        "year",
        "net",
        "profit",
        "million",
        "warteck",
        "invest",
        "reported",
        "full",
        "year",
        "profit",
        "million",
        "swiss",
        "franc",
        "vifor",
        "pharma",
        "said",
        "concluded",
        "agreement",
        "zeria",
        "market",
        "veltassa",
        "japan",
        "reporting",
        "zurich",
        "newsroom"
    ]
}